Page last updated: 2024-10-30

lansoprazole and Sensation Disorders

lansoprazole has been researched along with Sensation Disorders in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Sensation Disorders: Disorders of the special senses (i.e., VISION; HEARING; TASTE; and SMELL) or somatosensory system (i.e., afferent components of the PERIPHERAL NERVOUS SYSTEM).

Research Excerpts

ExcerptRelevanceReference
"In the dysphagia group, 48 of 54 patients (89%) had edema of the posterior larynx, and 42 of 54 (78%) had laryngopharyngeal sensory deficits."1.31Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia. ( Aviv, JE; Close, LG; Kaplan, ST; Liu, H; Parides, M, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aviv, JE1
Liu, H1
Parides, M1
Kaplan, ST1
Close, LG1

Other Studies

1 other study available for lansoprazole and Sensation Disorders

ArticleYear
Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia.
    The Annals of otology, rhinology, and laryngology, 2000, Volume: 109, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Deglutition Disorders; Fema

2000